艾美捷科技特约代理Avidity Biosciences公司产品。

Avidity Biosciences公司位于美国加州La Jolla，是一家专门从事抗体寡核苷酸结合物（AOC™）技术开发的生物技术公司，此项技术结合了单抗组织选择性和寡核苷酸疗法的精确性，克服了寡核苷酸给药屏障。

Avidity Biosciences is a privately-held biotech company pioneering Antibody Oligonucleotide Conjugates (AOC™). AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.

Antibody oligonucleotide conjugate (AOC™) technology

Avidity’s antibody oligonucleotide conjugate (AOC™) technology utilizes antibodies to target cells and tissues of interest and facilitate the uptake and internalization of oligonucleotide payloads. By combining the cellular and tissue selectivity of antibodies with the selectivity and efficiency of oligo-based approaches, Avidity has demonstrated modulation of disease-related RNAs in diverse cell types and tissues including muscle, heart, liver, tumors and immune cells.

艾美捷科技特约代理Aquatic Diagnostics全系列产品。

Aquatic Diagnostics依托于Stirling大学，为世界范围内的客户提供渔业健康管理产品。Aquatic Diagnostics公司主要研发和生产单抗试剂、抗体偶联试剂、快速检测试剂盒，主要应用方向为病原体检测（检测经济鱼类的致病原，如AquaMab-P和Rapid Kits）和鱼类免疫力筛查（AquaMab-F和AquaMab-C）。

Aquatic Diagnostics is an international biotechnology company operating within the Institute of Aquaculture at the University of Stirling. Aquatic Diagnostics develops and markets reagents (monoclonal antibodies and antibody conjugates) and Rapid Kits that can be used to improve fish health management. These products identify pathogens causing disease and enable screening of fish immunity.

Our Fish Health Management Products Detect:

1) Economically important fish pathogens (AquaMab-P and Rapid Kits)

2) Fish antibodies to monitor immune response in a variety of fish species (AquaMab-F and AquaMab-C)

To ensure ease of use, all fish health management products are supplied with standard protocols. Animations of the procedures are available on the website for each product, to enable customers to choose the most suitable method for successful results.

艾美捷科技代理Absolute Antibody重组抗体。

Absolute Antibody成立于2012年，其产品线100%专注于重组抗体。虽然重组抗体是制药行业的主流，但这些抗体尚未广泛用于诊断或研究。由于重组抗体比传统杂交瘤产生的单克隆抗体

具有许多优势，这种情况正在开始改变。

Absolute Antibody专注于抗体测序、抗体工程和抗体重组表达，并提供定制服务、重组抗体和Fc融合蛋白。Absolute Antibody的客户包括制药公司、生物技术和诊断公司，以及世界各

地的学术研究人员。此外，Absolute Antibody团队在治疗性抗体和重组表达技术领域拥有丰富的经验。自成立以来，Absolute Antibody已生产了180多种不同构型的抗体，并开发了逾

15000种重组抗体试剂。